INS and neoplasm: Experimental factors such as failure to consistently reduce glycemia/insulin (despite increases in ketonemia), diet initiation (before or after tumor implantation), composition (ketogenic ratio), and palatability, as well as ad libitum or restricted feeding, could account for diverging results even when using identical tumor models [151, 152].